Month: January 2025
-
Automakers infringe digital pass key patents by implementing Car Connectivity Consortium standard: new lawsuit against Hyundai, KIA
Biometrics firm Proxense, a former operating company, has expanded its patent enforcement action to the automotive industry with a lawsuit against Hyundai, KIA and Genesis.
-
Google follows Samsung in settling patent dispute with biometrics firm Proxense in Western District of Texas: Apple, Microsoft, Intel, LG cases still pending
Proxense and Google filed a stipulated dismissal on Monday, which amounts to a notice of settlement. Samsung already settled in 2023, but several other cases are still pending.
-
Avanci responds to Chinese study on automotive SEP license fees: “numerous inaccuracies”
Context: Commonly, when Avanci announces something, it involves new licensors or licensees (see, e.g., this October 9, 2024 ip fray article). Avanci’s automotive pool covers a very high percentage of all 4G and 5G standard-essential patents (SEPs), and most of the market (which for 5G depends on whether companies are already implementing it) is licensed….
-
AstraZeneca expands cancer drug patent enforcement campaign in U.S., seeks preliminary injunctions
AstraZeneca has filed four separate complaints against generic drugmakers Cipla, Sandoz, Natco, and Zydus in the United States District Court for the District of New Jersey.
-
Three attempts to use U.S. courts against German (or UPC) patent enforcement actions have failed in recent years: disproven recipe?
It has been tried three times over the past couple of years to leverage U.S. district courts against German courts or the UPC, and it produced nothing but costs.
-
NPE sues SK Hynix in Eastern District of Texas: alleges Dell, Microsoft and Nvidia also “indirectly” infringing semiconductor patents
Advanced Memory Technologies LLC, represented by litigation powerhouse Susman Godfrey, has accused SK Hynix of infringing four semiconductor-related patents.
-
“Some say power over people… I say achieving through and with people”: an interview with Bayer’s IP head Dr. Jörg Thomaier
In this interview, Dr. Jörg Thomaier, CEO of Bayer IP GmbH, reflects on over 27 years at the pharma giant, including helping transform the patent team from being a somewhat “neglected child” into a respected, functioning engine for the overall company.
-
Public version of Nokia v. Amazon ITC ruling in multimedia SEP case holds e-commerce giant responsible for unlicensed status
The public redacted version of a trade judge’s December 2024 ruling shows that Amazon was far from prevailing over Nokia on a FRAND defense.
-
Catalyst and Teva Pharmaceuticals settle patent dispute over rare-disease drug, but fight for orphan treatment not over yet
Nasadaq-listed Catalyst sees shares rise by 18% following the settlement, which grants Teva a license from February 2035.
-
UPC updates: Tesla settles with Broadcom; Dyson close to settling with SharkNinja; observations on December filings
Broadcom and Tesla have apparently settled their patent dispute. Dyson and SharkNinja appear to be close to settling their case. And some observations on UPC filings.